Drugmakers Hit With Suit Over Nerve-Damaging Antibiotic
Johnson & Johnson and Janssen were hit Thursday with a proposed class action in Pennsylvania federal court that accuses the companies of fraudulently misrepresenting and selling a class of antibiotics that...To view the full article, register now.
Already a subscriber? Click here to view full article